US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
DD266710A3
(de)
|
1983-06-06 |
1989-04-12 |
Ve Forschungszentrum Biotechnologie |
Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
|
DE3572982D1
(en)
|
1984-03-06 |
1989-10-19 |
Takeda Chemical Industries Ltd |
Chemically modified lymphokine and production thereof
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
US4879231A
(en)
|
1984-10-30 |
1989-11-07 |
Phillips Petroleum Company |
Transformation of yeasts of the genus pichia
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
GB8610600D0
(en)
|
1986-04-30 |
1986-06-04 |
Novo Industri As |
Transformation of trichoderma
|
US4881175A
(en)
|
1986-09-02 |
1989-11-14 |
Genex Corporation |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
WO1988007089A1
(en)
|
1987-03-18 |
1988-09-22 |
Medical Research Council |
Altered antibodies
|
US5013653A
(en)
|
1987-03-20 |
1991-05-07 |
Creative Biomolecules, Inc. |
Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
|
US5132405A
(en)
|
1987-05-21 |
1992-07-21 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
JPH02500329A
(ja)
|
1987-05-21 |
1990-02-08 |
クリエイテイブ・バイオマリキユールズ・インコーポレーテツド |
ターゲット化多機能蛋白質
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
US5677425A
(en)
|
1987-09-04 |
1997-10-14 |
Celltech Therapeutics Limited |
Recombinant antibody
|
GB8725529D0
(en)
|
1987-10-30 |
1987-12-02 |
Delta Biotechnology Ltd |
Polypeptides
|
US5476996A
(en)
|
1988-06-14 |
1995-12-19 |
Lidak Pharmaceuticals |
Human immune system in non-human animal
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
EP0401384B1
(en)
|
1988-12-22 |
1996-03-13 |
Kirin-Amgen, Inc. |
Chemically modified granulocyte colony stimulating factor
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
EP0402226A1
(en)
|
1989-06-06 |
1990-12-12 |
Institut National De La Recherche Agronomique |
Transformation vectors for yeast yarrowia
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
WO1991010741A1
(en)
|
1990-01-12 |
1991-07-25 |
Cell Genesys, Inc. |
Generation of xenogeneic antibodies
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
JPH03230220A
(ja)
|
1990-02-05 |
1991-10-14 |
Seiko Epson Corp |
ソート処理方法
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
ES2108048T3
(es)
|
1990-08-29 |
1997-12-16 |
Genpharm Int |
Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
DK0605522T3
(da)
|
1991-09-23 |
2000-01-17 |
Medical Res Council |
Fremgangsmåde til fremstilling af humaniserede antistoffer
|
WO1993008829A1
(en)
|
1991-11-04 |
1993-05-13 |
The Regents Of The University Of California |
Compositions that mediate killing of hiv-infected cells
|
ES2227512T3
(es)
|
1991-12-02 |
2005-04-01 |
Medical Research Council |
Produccion de anticuerpos contra auto-antigenos a partir de repertorios de segmentos de anticuerpos fijados en un fago.
|
CA2124967C
(en)
|
1991-12-17 |
2008-04-08 |
Nils Lonberg |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
WO1993022332A2
(en)
|
1992-04-24 |
1993-11-11 |
Board Of Regents, The University Of Texas System |
Recombinant production of immunoglobulin-like domains in prokaryotic cells
|
EP0656064B1
(en)
|
1992-08-17 |
1997-03-05 |
Genentech, Inc. |
Bispecific immunoadhesins
|
CA2161351C
(en)
|
1993-04-26 |
2010-12-21 |
Nils Lonberg |
Transgenic non-human animals capable of producing heterologous antibodies
|
ES2138662T3
(es)
|
1993-06-03 |
2000-01-16 |
Therapeutic Antibodies Inc |
Produccion de fragmentos de anticuerpos.
|
EP0714409A1
(en)
|
1993-06-16 |
1996-06-05 |
Celltech Therapeutics Limited |
Antibodies
|
SE9400088D0
(sv)
|
1994-01-14 |
1994-01-14 |
Kabi Pharmacia Ab |
Bacterial receptor structures
|
US5429746A
(en)
|
1994-02-22 |
1995-07-04 |
Smith Kline Beecham Corporation |
Antibody purification
|
TW581771B
(en)
|
1994-11-15 |
2004-04-01 |
Hayashibara Biochem Lab |
Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
JP2007121310A
(ja)
|
1996-07-31 |
2007-05-17 |
Hayashibara Biochem Lab Inc |
自己免疫疾患診断剤
|
JP2009047705A
(ja)
|
1996-07-31 |
2009-03-05 |
Hayashibara Biochem Lab Inc |
生物学的試料の検出方法
|
US7141393B2
(en)
|
1996-12-26 |
2006-11-28 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Interleukin-18-receptor proteins
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
EP1724282B1
(en)
|
1997-05-21 |
2013-05-15 |
Merck Patent GmbH |
Method for the production of non-immunogenic proteins
|
DE19742706B4
(de)
|
1997-09-26 |
2013-07-25 |
Pieris Proteolab Ag |
Lipocalinmuteine
|
CA2318482C
(en)
|
1998-01-23 |
2010-04-13 |
Immunex Corporation |
Il-18 receptors
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
PT1071700E
(pt)
|
1998-04-20 |
2010-04-23 |
Glycart Biotechnology Ag |
Modificação por glicosilação de anticorpos para melhorar a citotoxicidade celular dependente de anticorpos
|
CA2276216A1
(en)
|
1998-06-24 |
1999-12-24 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
An artificial peptide capable of neutralizing the biological activity of interleukin-18
|
IL127127A0
(en)
|
1998-11-18 |
1999-09-22 |
Peptor Ltd |
Small functional units of antibody heavy chain variable regions
|
US6818418B1
(en)
|
1998-12-10 |
2004-11-16 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
ES2694002T3
(es)
|
1999-01-15 |
2018-12-17 |
Genentech, Inc. |
Polipéptido que comprende una región Fc de IgG1 humana variante
|
AR022952A1
(es)
|
1999-03-19 |
2002-09-04 |
Smithkline Beecham Corp |
ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL
|
PT1914244E
(pt)
|
1999-04-09 |
2013-07-26 |
Kyowa Hakko Kirin Co Ltd |
Processo para regular a actividade de moléculas funcionais sob o ponto de vista imunológico
|
US6432678B1
(en)
|
1999-06-21 |
2002-08-13 |
Smithkline Beecham Corporation |
Macaca cynomolgus IL 18
|
DE19932688B4
(de)
|
1999-07-13 |
2009-10-08 |
Scil Proteins Gmbh |
Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen
|
EP1990409A3
(en)
|
1999-07-20 |
2011-05-18 |
MorphoSys AG |
Bacteriophage
|
EP1212422B1
(en)
|
1999-08-24 |
2007-02-21 |
Medarex, Inc. |
Human ctla-4 antibodies and their uses
|
JP3230220B2
(ja)
|
1999-10-07 |
2001-11-19 |
独立行政法人 農業技術研究機構 |
ブタ由来インターロイキン−18に対するモノクローナル抗体
|
DE60041432D1
(de)
|
1999-11-16 |
2009-03-12 |
Hayashibara Biochem Lab |
Antikörper spezifisch für den Interleukin-18 Vorläufer
|
NZ520392A
(en)
|
2000-02-10 |
2005-04-29 |
Abbott Lab |
Antibodies that bind human interleukin-18 and methods of making and using
|
TR200502061T2
(tr)
*
|
2000-02-21 |
2005-08-22 |
Research Systems Ars Holding N. V. Applied |
IL-18 inhibitörlerinin kullanımı.
|
MXPA02010895A
(es)
|
2000-05-05 |
2003-03-27 |
Applied Research Systems |
Uso de inhibidores de interleucina 18 para el tratamiento y/o prevencion de aterosclerosis.
|
DE60139720D1
(de)
|
2000-06-28 |
2009-10-08 |
Glycofi Inc |
Verfahren für die Herstellung modifizierter Glykoproteine
|
US6946292B2
(en)
|
2000-10-06 |
2005-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
|
AU2002224417A1
(en)
|
2000-10-18 |
2002-04-29 |
Immunex Corporation |
Methods for treating il-18 mediated disorders
|
ATE378403T1
(de)
|
2000-11-30 |
2007-11-15 |
Medarex Inc |
Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern
|
ES2295332T3
(es)
|
2001-01-29 |
2008-04-16 |
Laboratoires Serono Sa |
Uso de inhibidores de il-18 para el tratamiento y/o prevencion de cardiopatias.
|
US20050053973A1
(en)
|
2001-04-26 |
2005-03-10 |
Avidia Research Institute |
Novel proteins with targeted binding
|
US20040175756A1
(en)
|
2001-04-26 |
2004-09-09 |
Avidia Research Institute |
Methods for using combinatorial libraries of monomer domains
|
US20050048512A1
(en)
|
2001-04-26 |
2005-03-03 |
Avidia Research Institute |
Combinatorial libraries of monomer domains
|
EP1443961B1
(en)
|
2001-10-25 |
2009-05-06 |
Genentech, Inc. |
Glycoprotein compositions
|
AU2002365269A1
(en)
|
2001-10-26 |
2003-07-24 |
Centocor, Inc. |
Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
|
KR20050004809A
(ko)
|
2002-03-22 |
2005-01-12 |
어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. |
말초 맥관 질환 치료 및/또는 예방에 사용되는 il-18저해제
|
FR2838444B1
(fr)
|
2002-04-10 |
2016-01-01 |
Neovacs |
Nouveaux peptides et leur application en therapeutique
|
CA2523912A1
(en)
*
|
2003-04-30 |
2004-11-11 |
Japan Science And Technology Agency |
Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
|
DK1622939T3
(da)
|
2003-05-13 |
2012-04-10 |
Merck Serono Sa |
Aktive varianter af det IL-18-bindende protein og medicinske anvendelser deraf
|
DE10324447A1
(de)
|
2003-05-28 |
2004-12-30 |
Scil Proteins Gmbh |
Generierung künstlicher Bindungsproteine auf der Grundlage von Ubiquitin
|
PL1639011T3
(pl)
|
2003-06-30 |
2009-05-29 |
Domantis Ltd |
Pegilowane przeciwciała jednodomenowe (dAb)
|
JP2005052021A
(ja)
|
2003-08-07 |
2005-03-03 |
Yokohama City |
インターロイキン−18変異体タンパク質
|
US20050075702A1
(en)
|
2003-10-01 |
2005-04-07 |
Medtronic, Inc. |
Device and method for inhibiting release of pro-inflammatory mediator
|
US7968684B2
(en)
|
2003-11-12 |
2011-06-28 |
Abbott Laboratories |
IL-18 binding proteins
|
US20050100965A1
(en)
|
2003-11-12 |
2005-05-12 |
Tariq Ghayur |
IL-18 binding proteins
|
WO2005075648A1
(en)
|
2004-01-28 |
2005-08-18 |
Gifu University |
Interleukin-18 mutant proteins
|
EP1744734A2
(en)
|
2004-02-20 |
2007-01-24 |
Novo Nordisk A/S |
Therapeutic combination comprising a tissue factor antagonist and anti-cancer compounds
|
US7557084B2
(en)
|
2004-03-31 |
2009-07-07 |
Regeneron Pharmaceuticals, Inc. |
IL-18 specific polypeptides and therapeutic uses thereof
|
US20060008844A1
(en)
|
2004-06-17 |
2006-01-12 |
Avidia Research Institute |
c-Met kinase binding proteins
|
JP4673068B2
(ja)
|
2005-01-19 |
2011-04-20 |
独立行政法人科学技術振興機構 |
Th1型アレルギー疾患治療用組成物
|
EP1904846A4
(en)
|
2005-06-29 |
2009-03-18 |
Rules Based Medicine Inc |
METHOD AND KITS FOR THE DIAGNOSIS OF ACUTE CORONARY SYNDROME
|
US20090215992A1
(en)
|
2005-08-19 |
2009-08-27 |
Chengbin Wu |
Dual variable domain immunoglobulin and uses thereof
|
AU2006283532B2
(en)
|
2005-08-19 |
2012-04-26 |
Abbvie Inc. |
Dual variable domain immunoglobin and uses thereof
|
DK2578685T3
(da)
|
2005-08-23 |
2019-06-03 |
Univ Pennsylvania |
Rna indeholende modificerede nukleosider og fremgangsmåder til anvendelse deraf
|
JP4728785B2
(ja)
|
2005-11-30 |
2011-07-20 |
独立行政法人科学技術振興機構 |
Il−18の生物活性を有する新規ポリペプチドの生産方法、および当該ポリペプチドの産生を阻害する物質のスクリーニング方法
|
NZ572565A
(en)
|
2006-05-25 |
2011-04-29 |
Glaxo Group Ltd |
Modified humanised anti-interleukin-18 antibodies
|
CA3128656A1
(en)
|
2007-08-22 |
2009-02-26 |
The Regents Of The University Of California |
Activatable binding polypeptides and methods of identification and use thereof
|
JP2011511777A
(ja)
|
2008-01-30 |
2011-04-14 |
アボット・ラボラトリーズ |
抗体断片を結晶化するための組成物及び方法
|
CA2725666A1
(en)
|
2008-06-03 |
2009-12-10 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
NZ590074A
(en)
|
2008-07-08 |
2012-12-21 |
Abbott Lab |
Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
|
US20110150871A1
(en)
|
2008-08-18 |
2011-06-23 |
Glaxo Group Limited |
Treatment of an autoimmune disease using il-18 antagonists
|
WO2010040736A2
(en)
|
2008-10-07 |
2010-04-15 |
Ablynx Nv |
Amino acid sequences directed against il18 and/or the il-18 receptor and polypeptides comprising the same for the treatment of diseases and/or disorders associated with il-18 mediated signaling
|
NZ592097A
(en)
|
2008-10-20 |
2013-01-25 |
Abbott Lab |
Viral inactivation during purification of il-12 and il-18 antibodies
|
TW201030016A
(en)
|
2008-10-20 |
2010-08-16 |
Abbott Lab |
Antibodies that bind to IL-18 and methods of purifying the same
|
BRPI0923595A2
(pt)
|
2008-12-23 |
2016-01-26 |
Mtn Mobile Money Sa Pty Ltd |
método para processar seguramente uma transação, sistema para processar uma transação, e, dispositivo de comunicações móveis
|
AU2010242840B2
(en)
|
2009-05-01 |
2014-04-17 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
EP2534175A2
(en)
|
2010-02-09 |
2012-12-19 |
Glaxo Group Limited |
Treatment of a metabolic disorder
|
EP2655416A1
(en)
*
|
2010-12-20 |
2013-10-30 |
Medimmune Limited |
Anti-il-18 antibodies and their uses
|
JOP20200308A1
(ar)
|
2012-09-07 |
2017-06-16 |
Novartis Ag |
جزيئات إرتباط il-18
|
UY37758A
(es)
*
|
2017-06-12 |
2019-01-31 |
Novartis Ag |
Método de fabricación de anticuerpos biespecíficos, anticuerpos biespecíficos y uso terapéutico de dichos anticuerpos
|